What have we learned from the COVID-19 plague?


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
15 Sep 2021
Historique:
entrez: 15 9 2021
pubmed: 16 9 2021
medline: 23 9 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has been devastating, but it enables us to learn from it and prepare for the next pandemic disease.

Identifiants

pubmed: 34524858
doi: 10.1126/scitranslmed.abl9098
doi:

Types de publication

Editorial Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabl9098

Commentaires et corrections

Type : CommentOn

Auteurs

Stanley A Plotkin (SA)

University of Pennsylvania and CEO of Vaxconsult, Doylestown, PA 18902, USA. Email: stanley.plotkin@vaxconsult.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH